How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Donor Egg In Vitro Fertilization Services Market
- By Donor Egg Source: Fresh Donor Eggs, Frozen Donor Eggs, Anonymous Donor Eggs, Known Donor Eggs
- By Recipient Age Group: Under 35 Years, 35-40 Years, Above 40 Years
- By Service Provider Type: Fertility Clinics, Hospitals with IVF Centers, Specialized Reproductive Medicine Centers
- By Cycle Type: Fresh Embryo Transfer Cycles, Frozen Embryo Transfer Cycles
- By End-User Type: Primary Infertile Couples, Secondary Infertile Couples, Single Women, Same-Sex Couples
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fresh Donor Eggs leads By Donor Egg Source at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Donor Egg In Vitro Fertilization Services Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →IVF Centers of America
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CCRM (Colorado Center for Reproductive Medicine)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Shady Grove Fertility
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Boston IVF
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Reproductive Medicine Associates of New York (RMA)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Extend Fertility
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Fertility Centers of Illinois
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Pacific Fertility Center
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →New Hope Fertility Center
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Create Fertility
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Genea Fertility
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Monash IVF
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Bourn Hall Clinic
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Fertility Associates
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →The Fertility Partnership
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fresh Donor Eggs70.9
- Frozen Donor Eggs8.3
- Anonymous Donor Eggs9.1
- Known Donor Eggs11.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- IVF Centers of America14.8
- CCRM (Colorado Center for Reproductive Medicine)20.9
- Shady Grove Fertility9.3
- Boston IVF10.0
- Reproductive Medicine Associates of New York (RMA)7.6
- Extend Fertility9.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.4
- Europe24.1
- Asia Pacific18.9
- Latin America14.3
- Middle East and Africa9.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| IVF Centers of America | 88 | 74 | 87 | 84 | 96 | 80 | 85 |
| CCRM (Colorado Center for Reproductive Medicine) | 69 | 75 | 71 | 76 | 93 | 91 | 79 |
| Shady Grove Fertility | 85 | 84 | 71 | 77 | 81 | 76 | 79 |
| Boston IVF | 78 | 71 | 62 | 64 | 58 | 79 | 69 |
| Reproductive Medicine Associates of New York (RMA) | 69 | 75 | 53 | 52 | 58 | 61 | 61 |
| Extend Fertility | 50 | 70 | 62 | 61 | 59 | 47 | 58 |
| Fertility Centers of Illinois | 45 | 50 | 65 | 42 | 47 | 64 | 52 |
| Pacific Fertility Center | 42 | 38 | 50 | 52 | 48 | 45 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- IVF Centers of America
- CCRM (Colorado Center for Reproductive Medicine)
- Shady Grove Fertility
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| IVF Centers of America | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| CCRM (Colorado Center for Reproductive Medicine) | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Shady Grove Fertility | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Boston IVF | ✓ | ◐ | ◐ | ✓ | − | ◐ |
| Reproductive Medicine Associates of New York (RMA) | ◐ | ◐ | − | − | ◐ | ◐ |
| Extend Fertility | ◐ | ◐ | ◐ | − | − | ◐ |
| Fertility Centers of Illinois | − | − | ◐ | − | − | ◐ |
| Pacific Fertility Center | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Donor Egg Source in North America, then scale across Donor Egg In Vitro Fertilization Services Market — a $512M beachhead inside a $9.13B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Fresh Donor Eggs
Best fit — highest urgency & budget in Donor Egg Source.
Frozen Donor Eggs
Strong fit — clear ROI and a fast path to value.
Anonymous Donor Eggs
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Donor Egg Source in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Recipient Age Group & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Service Provider Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Donor Egg Source leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Donor Egg In Vitro Fertilization Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Donor Egg In Vitro Fertilization Services Market is a high-growth opportunity — $2.78B by 2033, compounding at 10.1%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.1% CAGR
Demand compounds through 2033, outpacing GDP across Donor Egg Source.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Donor Egg Source moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Recipient Age Group optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Donor Egg In Vitro Fertilization Services Market — a $5.61B market by 2033. Plan: grow share from 6.4% to 14.1%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.4% | 14.1% | At risk |
| Revenue | $391M | $791M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.0% | 43.8% | Ahead |
| Customer retention | 88.4% | 92.3% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Donor Egg Source
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Recipient Age Group capability
A defensible second engine — invest in Recipient Age Group to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Donor Egg Source share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Recipient Age Group
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $112M capacity & capability investment
- Greenlight bolt-on M&A in Recipient Age Group
- Authorise North America expansion plan
- Fund R&D program for Donor Egg Source leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentOn track
Sales deck · value proposition
Win the Donor Egg In Vitro Fertilization Services Market conversation — a $4.42B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Donor Egg Source
Goal Grow share in Donor Egg Source
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Donor Egg In Vitro Fertilization Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Donor Egg In Vitro Fertilization Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Donohue Syndrome Treatment Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportDonkey Antibody Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportDonepezil Hydrochloride Tablet Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportCitronellal Hydrate Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportDonepezil Hydrochloride Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportDonepezil Hydrochloride API Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportDonepezil Generic Drug Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportDonepezil for Alzheimer Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportLavandulol Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportDonepezil Drug Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportDonepezil Base Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportElectrolyte Iron Powder Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy